
Pilgrim’s Pride announced Wednesday, October 15, that it will pay more than US$110.5 million in a plea agreement with the US Department of Justice’s (DOJ) Antitrust Division.
The plea is related to the DOJ’s investigation into broiler chicken products, according to a news release. Earlier this year, senior executives from Colorado-based Pilgrim’s and Georgia-based Claxton Poultry Farms, both being major US chicken producers, were indicted for conspiring to fix prices and rig bids on broiler chickens, which are sold to grocery stores and restaurants, reported the Wall Street Journal.
“We are encouraged that today’s agreement concludes the Antitrust Division’s investigation into Pilgrim’s, providing certainty regarding this matter to our team members, suppliers, customers and shareholders,” Pilgrim’s Chief Executive Fabio Sandri said.
The one-count indictment leveled charges against former CEO Jayson Penn and former vice president, Roger Austin. The Wall Street Journal reported that Penn left the company in September.
“We are encouraged that today’s agreement concludes the Antitrust Division’s investigation into Pilgrim’s, providing certainty regarding this matter to our team members, suppliers, customers and shareholders,” said Fabio Sandri, interim CEO of Pilgrim’s.
Pilgrim’s is the second largest broiler chicken supplier in the US, after Tyson Foods.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas